The design of biodegradable ofloxacin-based core-shell microspheres: Influence of the formulation parameters on in vitro characterization

References

• Hamilton-Miller JMT, Shah S. Activities of ciprofloxacin, levofloxacin, ofloxacin and sparfloxacin against speciated coagulase-negative staphylococci sensitive and resistant to fluoroquinolones. Int J Antimicrob Ag 1997;9:127–130.
   PubMedGoogle Scholar
• Garcia I, Pascual A, Ballesta S, Perea EJ. Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cells. Int J Antimicrob Ag 2000;15:201–205.
   PubMedGoogle Scholar
• Zivanovic LJ, Zigic G, Zecevic M. Investigation of chromatographic conditions for the separation of ofloxacin and its degradation products. J Chromatogr A 2006;1119:224–230.
   PubMed Web of Science ®Google Scholar
• Basci NE, Hanioglu-Kargi S, Soysal H, Bozkurt A, Kayaalp SO. Determination of ofloxacin in human aqueous humour by high-performance liquid chromatography with fluorescence detection. J Pharmaceut Biomed Anal 1997;15:663–666.
   PubMed Web of Science ®Google Scholar
• Harsha SRC, Rani S. Ofloxacin targeting to lungs by way of microspheres. Int J Pharm 2009;380:127–132.
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang Y, Tang X. In vitro and in vivo evaluation of ofloxacin sustained release pellets. Int J Pharm 2008;360:47–52.
   PubMed Web of Science ®Google Scholar
• Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavia PR. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 2006;316:86–92.
   PubMed Web of Science ®Google Scholar
• Srividya B, Cordoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 2001;73:205–211.
   PubMed Web of Science ®Google Scholar
• Sezer AD, Baş AL, Akbuğa J. Encapsulation of enrofloxacin in liposomes I: Preparation and in vitro characterization of LUV. J Liposome Res 2004;14:77–86.
   PubMed Web of Science ®Google Scholar
• Sezer AD, Akbuğa J, Baş AL. In vitro evaluation of enrofloxacin-loaded MLV liposomes. Drug Deliv 2007;14:47–53.
   PubMed Web of Science ®Google Scholar
• Zaru M, Sinico C, De Logu A, Caddeo C, Lai F, Manca ML, Fadda AM. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation. J Liposome Res 2009;19:68–76.
   PubMed Web of Science ®Google Scholar
• Briones E, Colino CI, Lanao JM. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release 2008;125:210–227.
   PubMed Web of Science ®Google Scholar
• Kohane DS. Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng 2007;96:203–209.
   PubMed Web of Science ®Google Scholar
• Colo GD, Zambito Y, Burgalassi S, Nardini I, Saettone MF. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin. Int J Pharm 2004;273:37–44.
   PubMed Web of Science ®Google Scholar
• Yang L, Webster TJ. Nanotechnology controlled drug delivery for treating bone diseases. Exp Opin Drug Deliv, 2009;6:851–864.
   PubMed Web of Science ®Google Scholar
• Thierry B. Drug nanocarriers and functional nanoparticles: Applications in cancer therapy. Curr Drug Deliv 2009;6:391–403.
   PubMedGoogle Scholar
• Özbaş-Turan S, Aral C, Kabasakal L, Keyer-Uysal M, Akbuğa J. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. J Pharm Pharm Sci, 2003;6:27–32.
   PubMed Web of Science ®Google Scholar
• Akbuğa J, Özbaş-Turan S, Erdoğan N. Plasmid-DNA loaded chitosan microspheres for in vitro IL-2 expression. Eur J Pharm Biopharm, 2004;58:501–507.
   PubMed Web of Science ®Google Scholar
• Sezer AD, Akbuğa J. Fucosphere-new microsphere carriers for peptide and protein delivery: Preparation and in vitro characterization. J Microencaps 2006;23:513–522.
   PubMed Web of Science ®Google Scholar
• Özgel G, Akbuğa J. In vitro characterization and transfection of IL-2 gene complexes. Int J Pharm 2006;315:44–51.
   PubMed Web of Science ®Google Scholar
• Masotti A, Ortaggi G. Chitosan micro and nanospheres: Fabrication and applications for drug and DNA delivery. Mini Rev Med Chem 2009;9:463–469.
   PubMed Web of Science ®Google Scholar
• Sezer AD, Cevher E, Hatipoğlu F, Oğurtan Z, Baş AL, Akbuğa J. The use of fucosphere in the treatment of dermal burns in rabbits. Eur J Pharm Biopharm 2008;69:189–198.
   PubMed Web of Science ®Google Scholar
• Sezer AD, Cevher E, Hatipoğlu F, Oğurtan Z, Baş AL, Akbuğa J. Preparation of fucoidan-chitosan hydrogel and its application as burn healing accelerator on rabbits. Biol Pharm Bull 2008;31:2326–2333.
   PubMed Web of Science ®Google Scholar
• Rabea E, Badawy ME, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 2003;4:1457–1465.
   PubMed Web of Science ®Google Scholar
• Li B, Lu F, Wei X, Zhao R. Fucoidan: Structure and bioactivity. Molecules 2008;13:1671–1695.
   PubMed Web of Science ®Google Scholar
• Kusaykin M, Bakunina I, Sova V, Ermakova S, Kuznetsova T, Besednova N, Zaporozhets T, Zvyagintseva T. Structure, biological activity, and enzymatic transformation of fucoidans from the brown seaweeds. Biotechnol J 2008;3:904–915.
   PubMedGoogle Scholar
• Leary RO, Rerek M, Wood EJ. Fucoidan modulates the effect of transforming growth factor (TGF)-beta1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair. Biol Pharm Bull 2004;27:266–270.
   PubMedGoogle Scholar
• Berthold A, Cremer K, Kreuter J. Preparation and characterization of chitosan microspheres as drug carriers for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Release 1996;39:17–25.
   Web of Science ®Google Scholar
• Amrol D. Single-dose azithromycin microsphere formulation: A novel delivery system for antibiotics. Int J Nanomed 2007;2:9–12.
   PubMed Web of Science ®Google Scholar
• Werle M, Bernkop-Schnürch A. Thiolated chitosans: Useful excipients for oral drug delivery. J Pharma Pharmacol 2008;60:273–281.
   Web of Science ®Google Scholar
• Junghanns JU, Müler RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 2008;3:295–309.
   PubMed Web of Science ®Google Scholar
• Chen Y, Siddalingappa B, Chan PH, Benson HA. Development of a chitosan-based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin. Biopolymers 2008;90:663–670.
   PubMed Web of Science ®Google Scholar
• Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009;26:1025–1058.
   PubMed Web of Science ®Google Scholar
• Sezer AD, Akbuğa J. Comparison on in vitro characterization of fucospheres and chitosan microspheres encapsulated plasmid DNA (pGM-CSF): Formulation design and release characteristics. AAPS PharmSciTech 2009;10:1193–1199.
   PubMed Web of Science ®Google Scholar
• Anal AK, Stevens WF, Remuñán-López C. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int J Pharm 2006;312:166–173.
   PubMed Web of Science ®Google Scholar
• Liu YF, Huang KL, Peng DM, Ding P, Li GY. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate. Int J Biol Macromol, 2007;41:87–93.
   PubMed Web of Science ®Google Scholar
• Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004;104:6017–6084.
   PubMed Web of Science ®Google Scholar
• Kiang T, Wen J, Lim HW, Leong KW. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials 2004;25:5293–5301.
   PubMed Web of Science ®Google Scholar